Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 4
1(50.0%)
N/A
1(50.0%)
2Total
Phase 4(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02037919Not ApplicableCompleted

Nexplanon Application Post-Abortion (NAPA)

Role: lead

NCT04232189Terminated

Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before Abortion

Role: collaborator

NCT01457521Phase 4Completed

Pain Control In First Trimester Medical Abortion: A Randomized Trial

Role: collaborator

All 3 trials loaded